Anixa Biosciences (ANIX) Stock Statistics & Valuation Metrics

Anixa Biosciences has a market cap or net worth of $81.46M. The enterprise value is $118.13M.

Anixa Biosciences has 32.20M shares outstanding. The number of shares has decreased by -2.65% in one year.

Anixa Biosciences’s return on equity (ROE) is -0.63 and return on invested capital (ROIC) is -72.34%.

The current PE Ratio of Anixa Biosciences is -8.89. Anixa Biosciences’s PEG ratio is -0.41.

In the last 12 months, Anixa Biosciences had revenue of $0.00 and earned -$12.48M in profits. Earnings per share was -$0.39.

In the last 12 months, operating cash flow was -$7.93M and capital expenditures $0.00, giving a free cash flow of -$7.93M billion.

Anixa Biosciences pays an annual dividend of , resulting in a dividend yield of

Anixa Biosciences upcoming earnings date is Mar 8, 2024, TBA.

Anixa Biosciences as a current ratio of 8.54, with Debt / Equity ratio of 0.01

In the past 12 months, Anixa Biosciences has paid -$41.00K in taxes.

Anixa Biosciences EV to EBITDA ratio is -8.00, with an EV/FCF ratio of -15.08.

Anixa Biosciences has $17.25M in cash and marketable securities with $230.00K in debt, giving a net cash position of -$17.02M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Anixa Biosciences is $8.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy